Gown, Allen M.
The University of British Columbia,
Canada
2025 Rank: 76720
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 113 out of 25326 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 76720 | 85722 |
| Total Cites | 758 | 840 |
| H-index | 13 | 13 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 17 | 17 |
| Total Cites to Single Authored Papers | 23 | 23 |
| Number of Single+First Authored Papers | 42 | 42 |
| Total Cites to Single+First Authored Papers | 56 | 56 |
| Number of Single+First+Last Authored Papers | 151 | 151 |
| Total Cites to Single+First+Last Authored Papers | 173 | 175 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 654 | 707 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.19 |
| Self-Citation Percentage |
9.76%
|
|
Gown, Allen M.
The University of British Columbia,
Canada
2024 Rank: 81405
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 127 out of 24457 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 81405 | 89670 |
| Total Cites | 774 | 879 |
| H-index | 12 | 13 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 17 | 17 |
| Total Cites to Single Authored Papers | 17 | 17 |
| Number of Single+First Authored Papers | 42 | 42 |
| Total Cites to Single+First Authored Papers | 41 | 41 |
| Number of Single+First+Last Authored Papers | 151 | 151 |
| Total Cites to Single+First+Last Authored Papers | 151 | 152 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 664 | 717 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.23 |
| Self-Citation Percentage |
11.95%
|
|
Gown, Allen M.
The University of British Columbia,
Canada
2023 Rank: 62182
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 108 out of 23576 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 62182 | 68778 |
| Total Cites | 971 | 1043 |
| H-index | 13 | 14 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 19 | 19 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 40 | 40 |
| Number of Single+First+Last Authored Papers | 150 | 150 |
| Total Cites to Single+First+Last Authored Papers | 262 | 264 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 810 | 855 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.22 |
| Self-Citation Percentage |
6.90%
|
|
Gown, Allen M.
University of British Columbia, Faculty of Medicine,
Canada
2022 Rank: 49181
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 79 out of 23010 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 49181 | 50948 |
| Total Cites | 919 | 1013 |
| H-index | 13 | 15 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 27 | 27 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 47 | 47 |
| Number of Single+First+Last Authored Papers | 149 | 149 |
| Total Cites to Single+First+Last Authored Papers | 223 | 229 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 804 | 861 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.18 |
| Self-Citation Percentage |
9.28%
|
|
Gown, Allen M.
PhenoPath Laboratories,
United States
2021 Rank: 41458
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 76 out of 22656 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 41458 | 44326 |
| Total Cites | 1535 | 1665 |
| H-index | 17 | 19 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 37 | 37 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 86 | 86 |
| Number of Single+First+Last Authored Papers | 149 | 149 |
| Total Cites to Single+First+Last Authored Papers | 378 | 388 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1265 | 1343 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.24 |
| Self-Citation Percentage |
7.81%
|
|
Gown, Allen M.
PhenoPath Laboratories,
United States
2020 Rank: 42398
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 75 out of 19713 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 42398 | 47135 |
| Total Cites | 1095 | 1169 |
| H-index | 14 | 15 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 30 | 30 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 69 | 69 |
| Number of Single+First+Last Authored Papers | 148 | 148 |
| Total Cites to Single+First+Last Authored Papers | 304 | 311 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 920 | 970 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.21 |
| Self-Citation Percentage |
6.33%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.